CFGS

Concourse Financial Group Securities Portfolio holdings

AUM $1.77B
1-Year Return 17.35%
This Quarter Return
-15.27%
1 Year Return
+17.35%
3 Year Return
+18.06%
5 Year Return
+62.93%
10 Year Return
AUM
$906M
AUM Growth
-$102M
Cap. Flow
+$83M
Cap. Flow %
9.16%
Top 10 Hldgs %
24.29%
Holding
9,568
New
325
Increased
777
Reduced
665
Closed
168

Sector Composition

1 Technology 5.03%
2 Healthcare 4.18%
3 Financials 3.81%
4 Consumer Staples 3.18%
5 Communication Services 2.55%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
EMFQ
4926
DELISTED
Amplify Emerging Markets FinTech ETF
EMFQ
0
AMK
4927
DELISTED
AssetMark Financial Holdings, Inc.
AMK
0
CBH
4928
DELISTED
Virtus Convertible & Income 2024 Target Term Fund
CBH
0
ASXC
4929
DELISTED
Asensus Surgical, Inc.
ASXC
0
ATRI
4930
DELISTED
Atrion Corp
ATRI
0
BIMI
4931
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
0
MMAT
4932
DELISTED
Meta Materials Inc. Common Stock
MMAT
0
AIU
4933
DELISTED
Meta Data Limited American Depositary Shares, each representing ten (10) Class A Ordinary Shares
AIU
0
MORF
4934
DELISTED
Morphic Holding, Inc. Common Stock
MORF
0
GRIN
4935
DELISTED
Grindrod Shipping Holdings Ltd. Ordinary Shares
GRIN
0
IAUF
4936
DELISTED
iShares Gold Strategy ETF
IAUF
0
HEWG
4937
DELISTED
iShares Currency Hedged MSCI Germany ETF
HEWG
0
LL
4938
DELISTED
LL Flooring Holdings, Inc.
LL
$0 ﹤0.01%
50
ISZE
4939
DELISTED
iShares MSCI Intl Size Factor ETF
ISZE
0
WPS
4940
DELISTED
iShares International Developed Property ETF
WPS
0
VBIV
4941
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
0
CNTG
4942
DELISTED
Centogene N.V. Common Shares
CNTG
0
TWOU
4943
DELISTED
2U, Inc.
TWOU
0
CONN
4944
DELISTED
Conn's Inc.
CONN
0
FREE
4945
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
0
BCDAW
4946
DELISTED
BioCardia, Inc. Warrant
BCDAW
0
SDPI
4947
DELISTED
Superior Drilling Products Inc.
SDPI
0
MCBC
4948
DELISTED
Macatawa Bank Corp
MCBC
0
CALB
4949
DELISTED
California BanCorp Common Stock
CALB
0
ZVRA icon
4950
Zevra Therapeutics
ZVRA
$445M
0